about
Molecular targets for flavivirus drug discoveryMouse models of dengue virus infection for vaccine testingInnate immunity evasion by Dengue virusDengue virus pathogenesis: an integrated viewHumanized mice show clinical signs of dengue fever according to infecting virus genotypeA model of DENV-3 infection that recapitulates severe disease and highlights the importance of IFN-γ in host resistance to infectionDengue virus markers of virulence and pathogenicityDengue virus-induced hemorrhage in a nonhuman primate modelA non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 miceA genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent miceIssues related to recent dengue vaccine development.Dengue virus tropism in humanized mice recapitulates human dengue fever.Cells in dengue virus infection in vivo.Current progress in dengue vaccinesProtection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1.Human-animal chimeras for vaccine development: an endangered species or opportunity for the developing world?Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology.The role of the mosquito in a dengue human infection modelComparative pathogenesis of Alkhumra hemorrhagic fever and Kyasanur forest disease viruses in a mouse model.Invariant NKT cell response to dengue virus infection in human.Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination.Development of a humanized antibody with high therapeutic potential against dengue virus type 2CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in miceDengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro.The pathology of severe dengue in multiple organs of human fatal cases: histopathology, ultrastructure and virus replication.MicroRNA-30e* suppresses dengue virus replication by promoting NF-κB-dependent IFN productionInsights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design.Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence.Mouse STAT2 restricts early dengue virus replicationHuman dignity and the creation of human-nonhuman chimeras.Characterization of lethal dengue virus type 4 (DENV-4) TVP-376 infection in mice lacking both IFN-α/β and IFN-γ receptors (AG129) and comparison with the DENV-2 AG129 mouse model.Duck Tembusu Virus Exhibits Pathogenicity to Kunming Mice by Intracerebral Inoculation.The importance of hematopoietic progenitor cells in dengue.Unmasking the role of mast cells in dengueContributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage.Development of a transmission model for dengue virusCLEC5A is critical for dengue virus-induced osteoclast activation and bone homeostasis.Induction of neutralizing antibodies against four serotypes of dengue viruses by MixBiEDIII, a tetravalent dengue vaccineUtility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing
P2860
Q21999123-A69C437F-8311-42D1-A5A8-0CBF3EFBD4D9Q24276139-42108AE7-59D2-4FEC-B87B-F9FEBE9F347BQ24627203-C6C43A0A-93BF-4761-BA6B-FBD55054AA57Q24645380-40DCA783-193D-4F35-8375-1C80112CFF73Q24658429-4E9DFABB-35BC-403B-80A9-0045804B342BQ27305445-1E821E90-53E7-4B17-9A92-2C7AACE13305Q27490922-99BAEB2B-AF4D-44E9-8F2D-ABA11BEA6008Q27491021-DFD27582-F506-4A5B-941B-2D421AB1A7E9Q28473775-C0445939-351F-484C-8E93-81A86493CBE4Q28483765-66FFBE74-DBDC-4BFE-97DE-0123A6A4994DQ30395396-7D539CB4-1C2F-4B61-8CC4-C12CD09BFAD9Q33395882-A7527263-7F86-4D95-AFC1-F46C854C4AC6Q33399680-A148F6C1-943D-4F19-BADF-CF5099AFE1FBQ33408300-2E7DBDF2-E9EC-4299-8B7D-65AA437AB277Q33414156-8D92B6B3-016A-4E63-B71E-41F8ECBBD6FEQ33581276-15695ADF-BD57-4D4E-9097-90425C3820FCQ33610555-75AE26C3-2742-47FA-A338-882991B16C12Q33676847-AD5F5018-0115-4250-BB10-02DE6958F8E8Q33748175-BDF4FC38-20B0-4A8B-95BD-3A13D0732FA8Q33778714-6E9A4DBB-1B34-4407-A1CB-B64AAEFE6619Q33959381-CFECC909-8B72-4B15-9EF3-69958B23BB2CQ34234563-BAEDCE1B-E5C8-41C7-AE6D-2DAE4358A33CQ34260219-0BE0D9BE-4D67-4CB6-9112-EBB2A5FB5BF3Q34289194-5D081C3A-93F3-4546-B8FD-B1BF2F4C099AQ34386354-293B2FE5-9E28-456C-85DB-507ACD657052Q35149005-163C143A-E576-4494-9806-E9192AB9F7F3Q35224802-5B81BB08-8F94-4C8D-A065-36CC88D66492Q35268996-28A9A2AA-507F-484F-A67B-540EA9D2F916Q35382814-E90C5F74-E3C9-4CE6-B7E3-48887E28E014Q35846922-83A1723A-1F5E-4BD2-B1AE-A10DB0AB5017Q36113563-56D34056-1C17-4B2A-A590-52C9AFCB81F6Q36255068-15F3CEA8-3D94-40A9-8432-45E8E26EA1C7Q36594879-94DD10D6-B338-48D4-BBAB-08BB5FFC103DQ36612659-D3A381E5-2DF1-4FF5-AD66-9BD862EFE2D6Q36804415-192CA2C0-FEEF-4FBB-AB50-6D3EA5FEBE2FQ36804428-00E54C57-D507-4DE3-A2F5-2462D6F73440Q36859054-59AE184E-BFA6-4860-841A-8D3C7661845CQ37192419-DA799F9D-DFBB-4C47-8863-EEDB7B2AD64DQ37500519-8696AA57-969E-4297-941F-086229AD8CA5Q37547052-0ECF89F4-69FF-4E9B-BD98-DE870AA1F160
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mouse models of dengue virus infection and disease.
@en
Mouse models of dengue virus infection and disease.
@nl
type
label
Mouse models of dengue virus infection and disease.
@en
Mouse models of dengue virus infection and disease.
@nl
prefLabel
Mouse models of dengue virus infection and disease.
@en
Mouse models of dengue virus infection and disease.
@nl
P2860
P1433
P1476
Mouse models of dengue virus infection and disease.
@en
P2093
Lauren E Yauch
P2860
P356
10.1016/J.ANTIVIRAL.2008.06.010
P5008
P577
2008-07-09T00:00:00Z